يعرض 1 - 10 نتائج من 50 نتيجة بحث عن '"Shaad Essa Abdullah"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown

    المؤلفون: Yashaswi Shrestha, Ronald Herbst, Rajiv Raja, Maria Libera Ascierto, Michael Oberst, Philip Martin, Melissa de los Reyes, Nabendu Pore, Raymond Rothstein, John Meekin, Ashok K. Gupta, Melanie M. Frigault, Stephen Blackmore, Ina Bisha, Nathan Standifer, Shaad Essa Abdullah, Theresa Proia, Matthew Griffin, Phillip A. Dennis, Rebecca A. Halpin, Song Wu, Ricardo J Miragaia, Kathy Mulgrew, J. Carl Barrett, Maria Jure-Kunkel

    المصدر: Cancer Discovery. 11:2828-2845

    مصطلحات موضوعية: Tumor microenvironment, Durvalumab, Myeloid, business.industry, medicine.medical_treatment, Immunotherapy, medicine.disease, medicine.disease_cause, Blockade, medicine.anatomical_structure, Oncology, Cancer research, Medicine, KRAS, business, Lung cancer, Tremelimumab, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d257dcdf2537de8a2e48f2065188002a
    https://doi.org/10.1158/2159-8290.cd-20-1543

    أضف إلى المفضلة
  2. 2
    Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108

    المؤلفون: Alexandra Drakaki, Michael S. Gordon, Shaad Essa Abdullah, Wenmei Huang, Michael Ong, Jingsong Zhang, Natasha Angra, Pralay Mukhopadhyay, Xiang Guo, Arnold Degboe, Srikala S. Sridhar, Ashok K. Gupta, Alexander I. Spira, Hendrick Tobias Arkenau, Terence W. Friedlander, Peter H. O'Donnell, Lorin Roskos

    المصدر: Cancer. 126:432-443

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Bladder cancer, Durvalumab, business.industry, Locally advanced, Cancer, medicine.disease, Inflammatory biomarkers, humanities, 03 medical and health sciences, 0302 clinical medicine, Quality of life, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, 030212 general & internal medicine, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::12fbe85d31acd7158f02845553ce089c
    https://doi.org/10.1002/cncr.32532

    View record at Wiley
    أضف إلى المفضلة
  3. 3
    Treatment with tebentafusp beyond radiographic progressive disease (PD) in metastatic uveal melanoma (mUM)

    المؤلفون: Ryan J. Sullivan, Mohammed M. Milhem, Lev V. Demidov, Karl D. Lewis, Max Schlaak, Sophie Piperno-Neumann, Shaad Essa Abdullah, Claire Watkins, Howard Goodall, John M. Kirkwood

    المصدر: Journal of Clinical Oncology. 40:9585-9585

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a21ec97a8d657041426f6a05b8a3e75e
    https://doi.org/10.1200/jco.2022.40.16_suppl.9585

    أضف إلى المفضلة
  4. 4
    Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM)

    المؤلفون: Mark R. Middleton, Omid Hamid, Alexander Noor Shoushtari, Friedegund Elke Meier, Todd Michael Bauer, April K.S. Salama, John M. Kirkwood, Paolo Antonio Ascierto, Paul Lorigan, Cornelia Mauch, Marlana M. Orloff, T.R. Jeffry Evans, Shaad Essa Abdullah, Yuan Yuan, James Mitchell, Jessica Cecile Hassel

    المصدر: Journal of Clinical Oncology. 40:104-104

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d34f10d95e5d18760102d0daaeb06f9f
    https://doi.org/10.1200/jco.2022.40.16_suppl.104

    أضف إلى المفضلة
  5. 5
    Analysis of the effect of systemic corticosteroids on survival from tebentafusp in a phase 3 trial of metastatic uveal melanoma

    المؤلفون: Alexandra Ikeguchi, Joseph J. Sacco, Jason J. Luke, T.R. Jeffry Evans, Brendan D. Curti, Kevin B. Kim, Shaad Essa Abdullah, Claire Watkins, Ozgur Karakuzu, Paul D. Nathan

    المصدر: Journal of Clinical Oncology. 40:9584-9584

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f24ec4988c674d6fefc9b5deab4b69e4
    https://doi.org/10.1200/jco.2022.40.16_suppl.9584

    أضف إلى المفضلة
  6. 6
    1018P Characterization of liver function tests following tebentafusp in phase III randomized trial comparing tebentafusp with investigator’s choice in first line metastatic uveal melanoma (mUM)

    المؤلفون: Shaad Essa Abdullah, Bartosz Chmielowski, Igor Puzanov, P. Mendez, S. Lockwood, P.A. Ascierto, Friedegund Meier, Ellen Kapiteijn

    المصدر: Annals of Oncology. 32:S856-S857

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Melanoma, First line, Hematology, medicine.disease, law.invention, Randomized controlled trial, law, Internal medicine, Medicine, business, Liver function tests

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2db0da610afd906fabda9e537035a452
    https://doi.org/10.1016/j.annonc.2021.08.1402

    أضف إلى المفضلة
  7. 7
    1770P Genomic correlates of clinical outcomes in patients with metastatic uveal melanoma (mUM) treated with tebentafusp (tebe)

    المؤلفون: Shaad Essa Abdullah, Joseph J. Sacco, Laura C. Collins, S. Stanhope, L. de la Cruz Merino, Koustubh Ranade, Z. Eroglu, A. Greenshields-Watson

    المصدر: Annals of Oncology. 32:S1214-S1215

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, Melanoma, medicine, In patient, Hematology, business, medicine.disease

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::101ae24f6f9be244c66f175db21b2c88
    https://doi.org/10.1016/j.annonc.2021.08.1714

    أضف إلى المفضلة
  8. 8
    Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

    المؤلفون: Andrea Necchi, Daniel Hennessy, Juliane Manitz, Toni K. Choueiri, Noah M. Hahn, Shaad Essa Abdullah, Chen Gao, Constanze Kaiser, Ashok K. Gupta, Sandy Srinivas, Andrea B. Apolo, Jonathan E. Rosenberg, Darren Tayama, Doris Makari, Gregory R. Pond, Guru Sonpavde, Dean F. Bajorin, Matthew D. Galsky, Thomas Powles, Petros Grivas, Robert Dreicer, Guenter Niegisch

    المساهمون: Sonpavde, G., Manitz, J., Gao, C., Tayama, D., Kaiser, C., Hennessy, D., Makari, D., Gupta, A., Abdullah, S. E., Niegisch, G., Rosenberg, J. E., Bajorin, D. F., Grivas, P., Apolo, A. B., Dreicer, R., Hahn, N. M., Galsky, M. D., Necchi, A., Srinivas, S., Powles, T., Choueiri, T. K., Pond, G. R.

    المصدر: J Urol

    مصطلحات موضوعية: Oncology, Male, Time Factors, 030232 urology & nephrology, Datasets as Topic, Kaplan-Meier Estimate, carcinoma, B7-H1 Antigen, Carboplatin, neoplasm metastasis, 0302 clinical medicine, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, platinum, Immune Checkpoint Inhibitors, Aged, 80 and over, biology, Clinical Trials, Phase I as Topic, Middle Aged, Prognosis, drug therapy, transitional cell, Female, Adult, medicine.medical_specialty, Urologic Neoplasms, Metastatic Urothelial Carcinoma, Urology, MEDLINE, Risk Assessment, Article, 03 medical and health sciences, Pharmacotherapy, Clinical Trials, Phase II as Topic, Internal medicine, PD-L1, medicine, Overall survival, Carcinoma, Humans, Aged, Neoplasm Staging, Platinum, Carcinoma, Transitional Cell, business.industry, medicine.disease, Nomograms, Urinary Bladder Neoplasms, Prognostic model, biology.protein, prognosis, Cisplatin, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcc9745812a737a93076ffdb93d9956
    https://pubmed.ncbi.nlm.nih.gov/32552295

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  9. 9
    274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer

    المؤلفون: Song Wu, Matthew D. Hellmann, Han Si, Jean-Charles Soria, Maria Libera Ascierto, Rajiv Raja, Caroline Germa, Nathan Standifer, Chris Morehouse, Carl Barrett, Shaad Essa Abdullah, Marlon Rebelatto

    المصدر: Regular and young investigator award abstracts.

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunotherapy, CD38, medicine.disease, Blockade, Clinical trial, Immunophenotyping, Immune system, Internal medicine, medicine, Lung cancer, business, CD8

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7325ac0d91719d52772fb184d980e0c5
    https://doi.org/10.1136/jitc-2020-sitc2020.0274

    أضف إلى المفضلة
  10. 10
    Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

    المؤلفون: Michiel S. van der Heijden, Qu Zhang, Todd Hembrough, Song Wu, Shaad Essa Abdullah, Han Si, Matthew D. Hellmann, J. Carl Barrett, Wenjing Xu, Chen Gao, Phillip A. Dennis, Brandon Higgs, Neil H. Segal, Jamie E. Chaft, Jia Luo

    المصدر: Cancer Discov

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Prognostic variable, medicine.medical_specialty, Durvalumab, medicine.medical_treatment, Article, Circulating Tumor DNA, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Neoplasms, Medicine, Humans, Immune Checkpoint Inhibitors, Survival analysis, business.industry, Immunotherapy, Prognosis, Survival Analysis, Immune checkpoint, Blockade, 030104 developmental biology, 030220 oncology & carcinogenesis, Biomarker (medicine), business, Tremelimumab, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::909d65f816cb0242ece807d8f0bb0dfc
    https://pubmed.ncbi.nlm.nih.gov/32816849

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء